Compare POCI & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POCI | ORIS |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | China |
| Employees | N/A | 69 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 3.7M |
| IPO Year | N/A | 2024 |
| Metric | POCI | ORIS |
|---|---|---|
| Price | $4.19 | $0.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.4K | ★ 2.0M |
| Earning Date | 11-13-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | ★ $21,575,039.00 | $12,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $271.51 |
| Revenue Growth | ★ 13.67 | N/A |
| 52 Week Low | $3.77 | $0.08 |
| 52 Week High | $5.34 | $2.85 |
| Indicator | POCI | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 31.10 |
| Support Level | $4.04 | $0.10 |
| Resistance Level | $4.30 | $0.11 |
| Average True Range (ATR) | 0.25 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 23.30 | 37.14 |
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).